Dust mite allergy: Immunological mechanisms, Environmental impact, Genetic susceptibility, Diagnosis, Therapeutic strategies & Preventive measures

Dust mite allergy is a common condition caused by hypersensitivity to proteins found in dust mite feces, shed skin, and secretions, which triggers excessive IgE production. This allergy is strongly linked to asthma, allergic rhinitis, and atopic dermatitis. The primary culprits, Dermatophagoides pteronyssinus and Dermatophagoides farinae, thrive in warm, humid environments and are considered major indoor allergens. Diagnosis typically relies on skin prick tests and measurements of serum IgE, although emerging research is now exploring molecular diagnostic techniques.

Treatment options include allergen avoidance, antihistamines, corticosteroids, and immunotherapy; however, new approaches are investigating biologics, probiotics, and immunomodulatory therapies. Recent studies emphasize the importance of indoor air quality, humidity control, and allergen-proof materials in minimizing exposure. Interventions such as air purifiers and hypoallergenic bedding are being continually evaluated for their effectiveness.

There is also growing evidence of genetic predisposition, with studies identifying susceptible genes and examining how environmental factors affect gene expression. As the prevalence of dust mite allergies rises worldwide, ongoing research aims to refine diagnostic methods, develop more effective treatments, and create better prevention strategies to improve patient outcomes.

The most significant challenge in dust mite allergy research is the lack of precise and long-lasting treatment options. Current therapies, including antihistamines, corticosteroids, and immunotherapy, provide only temporary symptom relief and do not offer a permanent cure. Additionally, allergen avoidance strategies are often ineffective, mainly because dust mites are pervasive in indoor environments—especially in the warm and humid conditions common to tropical countries. Treatment outcomes are further complicated by variability in individual immune responses and genetic susceptibility. Given these challenges, research should focus on novel immunomodulatory therapies, such as biologics (e.g., monoclonal antibodies targeting IgE or cytokines), which may offer longer-lasting relief. Identifying genetic and epigenetic markers could enable the development of targeted treatments tailored to an individual’s immune profile. Furthermore, exploring new materials and technologies—including anti-mite fabrics, nanotechnology-based air purifiers, and advanced humidity regulation systems—could help reduce indoor allergen exposure more effectively. Lastly, the development of highly sensitive molecular diagnostics may facilitate early detection and intervention in dust mite-related allergic diseases.

This research topic covers multiple aspects of dust mite allergy, ranging from immunological mechanisms to treatment strategies and preventive measures. Some specific themes that contributors can address include:

1. Immunology and Pathophysiology: Investigating IgE responses, inflammatory pathways and cross-reactivity.
2. Diagnosis: Molecular diagnostics, component-resolved testing and biomarkers for early detection and monitoring.
3. Treatment Strategies and Novel Therapeutic Approaches: Advances in allergen-specific immunotherapy (subcutaneous vs. sublingual), biologics, probiotics and microbiome-based therapies.
4. Environmental and Preventive Strategies: Assessing indoor air quality, climate effects, urbanization, allergen-proof materials and humidity control.
5. Genetics and Epigenetics: Identifying genetic markers, hereditary risks, family-based studies and epigenetic modifications in immune responses.
6. Public Health and Epidemiology: Analyzing global trends, risk factors, socioeconomic influences and awareness strategies.

We welcome all types of manuscripts within the journal's scope to enhance diagnostics, improve treatments and establish preventive strategies for better management of dust mite allergy in near future.

Dr. Arghya Laha is affiliated with Hapten Biosystems, a private company involved in in-vitro allergy diagnostics. All other Topic Editors declare no competing interests with regards to the Research Topic subject.

Keywords: Dust mite hypersensitivity, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Skin prick test, IgE, Molecular diagnostics, Allergen avoidance, Antihistamines, Corticosteroids, Immunotherapy, Indoor air quality, Probiotics, Immunomodulation

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.